Visual and pharmacotherapy outcomes after transverse sinus stenting for idiopathic intracranial hypertension
Armin Handzic, Jim Shenchu Xie, Eef Hendriks, Pascal Mosimann, Patrick Nicholson, Jonathan Micieli, Edward Margolin
doi: https://doi.org/10.1101/2023.10.23.23297230
Armin Handzic
1University of Toronto, Faculty of Medicine, Department of Ophthalmology and Vision Sciences, Toronto, Ontario, Canada
MDJim Shenchu Xie
2Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada
Eef Hendriks
3University of Toronto, Faculty of Medicine, Department of Medical Imaging, Division of Neuroradiology, Toronto, Ontario
MDPascal Mosimann
3University of Toronto, Faculty of Medicine, Department of Medical Imaging, Division of Neuroradiology, Toronto, Ontario
MDPatrick Nicholson
3University of Toronto, Faculty of Medicine, Department of Medical Imaging, Division of Neuroradiology, Toronto, Ontario
MDJonathan Micieli
1University of Toronto, Faculty of Medicine, Department of Ophthalmology and Vision Sciences, Toronto, Ontario, Canada
4University of Toronto, Faculty of Medicine, Department of Medicine, Division of Neurology, Toronto, Ontario, Canada
5Kensington Vision and Research Center, Toronto, Ontario, Canada
MDEdward Margolin
1University of Toronto, Faculty of Medicine, Department of Ophthalmology and Vision Sciences, Toronto, Ontario, Canada
4University of Toronto, Faculty of Medicine, Department of Medicine, Division of Neurology, Toronto, Ontario, Canada
MDData Availability
All data produced in the present study are available upon reasonable request to the authors.
Posted October 25, 2023.
Visual and pharmacotherapy outcomes after transverse sinus stenting for idiopathic intracranial hypertension
Armin Handzic, Jim Shenchu Xie, Eef Hendriks, Pascal Mosimann, Patrick Nicholson, Jonathan Micieli, Edward Margolin
medRxiv 2023.10.23.23297230; doi: https://doi.org/10.1101/2023.10.23.23297230
Visual and pharmacotherapy outcomes after transverse sinus stenting for idiopathic intracranial hypertension
Armin Handzic, Jim Shenchu Xie, Eef Hendriks, Pascal Mosimann, Patrick Nicholson, Jonathan Micieli, Edward Margolin
medRxiv 2023.10.23.23297230; doi: https://doi.org/10.1101/2023.10.23.23297230
Subject Area
Subject Areas
- Addiction Medicine (380)
- Allergy and Immunology (697)
- Anesthesia (187)
- Cardiovascular Medicine (2823)
- Dermatology (242)
- Emergency Medicine (426)
- Epidemiology (12517)
- Forensic Medicine (10)
- Gastroenterology (799)
- Genetic and Genomic Medicine (4397)
- Geriatric Medicine (399)
- Health Economics (712)
- Health Informatics (2831)
- Health Policy (1044)
- Hematology (372)
- HIV/AIDS (893)
- Medical Education (412)
- Medical Ethics (113)
- Nephrology (460)
- Neurology (4155)
- Nursing (220)
- Nutrition (614)
- Oncology (2188)
- Ophthalmology (622)
- Orthopedics (254)
- Otolaryngology (316)
- Pain Medicine (263)
- Palliative Medicine (81)
- Pathology (484)
- Pediatrics (1166)
- Primary Care Research (481)
- Public and Global Health (6738)
- Radiology and Imaging (1480)
- Respiratory Medicine (896)
- Rheumatology (429)
- Sports Medicine (361)
- Surgery (469)
- Toxicology (57)
- Transplantation (198)
- Urology (173)